The opportunistic pathogen Pseudomonas aeruginosa can metabolize carnitine and O-acylcarnitines, which are abundant in host muscle and other tissues. Acylcarnitines are metabolized to carnitine and a fatty acid. The liberated carnitine and its catabolic product, glycine betaine, can be used as osmoprotectants, to induce the secreted phospholipase C PlcH, and as sole carbon, nitrogen and energy sources. P. aeruginosa is incapable of de novo synthesis of carnitine and acylcarnitines, therefore they must be imported from an exogenous source. In this study, we present the first characterization of bacterial acylcarnitine transport. Short-chain acylcarnitines are imported by the ABC transporter CaiX-CbcWV. Medium-and long-chain acylcarnitines (MCACs and LCACs) are hydrolysed extracytoplasmically and the free carnitine is transported primarily through CaiX-CbcWV. These findings suggest that the periplasmic protein CaiX has a binding pocket that permits short acyl chains on its carnitine ligand and that there are one or more secreted hydrolases that cleave MCACs and LCACs. To identify the secreted hydrolase(s), we used a saturating genetic screen and transcriptomics followed by phenotypic analyses, but neither led to identification of a contributing hydrolase, supporting but not conclusively demonstrating redundancy for this activity.
INTRODUCTION
Pseudomonas aeruginosa is a widely encountered environmental Gram-negative bacterium that is also an important opportunistic pathogen in humans. Some of the success of P. aeruginosa is thought to be due to metabolic flexibility that allows survival and growth in different environments. The P. aeruginosa genome encodes enzymes involved in diverse metabolic pathways, including catabolism of host-derived quaternary amine compounds (QACs) such as choline, glycine betaine, carnitine and acylcarnitines. Acylcarnitines are carnitine molecules in which a fatty acid has been added to the hydroxyl oxygen on the third carbon (Fig. 1a) . Carnitine and acylcarnitines are found in soil [1, 2] and plants [3, 4] , and are abundant in animal tissues where they function to transport lipids into the mitochondria for b-oxidation [5] . While the majority of carnitine is found in its free form, a portion is acylated, with acetylcarnitine being the most abundant acylcarnitine in animals [6, 7] .
P. aeruginosa has the capacity to metabolize carnitine [8] and acylcarnitines [9] . Short-chain acylcarnitines (SCACs), acetyl-and butyryl-carnitine, are hydrolysed in the cytosol by the soluble hydrolase HocS [9] , which is encoded as the last gene in the carnitine catabolic operon (Fig. 1b) . The MCAC and LCAC hydrolase(s) remain unidentified. Acylcarnitine hydrolysis yields a free fatty acid and carnitine. The resulting carnitine and its catabolic product glycine betaine function as osmoprotectants in hyperosmotic environments [9] [10] [11] , induce the secreted phospholipase C virulence factor PlcH [10] , and can be used as sole carbon, nitrogen and energy sources [9, 12, 13] . The liberated fatty acid can also be used as a sole carbon source [14] .
To date, de novo synthesis of carnitine has not been demonstrated in bacteria [15] , therefore, it must be acquired from the environment. There are two known routes for carnitine transport: (i) via a betaine/choline/carnitine transporter (BCCT), driven by sodium motive force, proton motive force or substrate:product antiport [16] ; and/or (ii) via an adenosine triphosphate (ATP)-binding cassette (ABC) transporter powered by ATP hydrolysis. In bacteria, ABC transporters are encoded as multiple polypeptides that form the functional transporter: a transmembrane domain, a nucleotide-binding domain (ATPase), and a substrate-binding protein (also known as a periplasmic-binding protein) [17] . In P. aeruginosa, the genes encoding the ABC transporter for the carnitine import are located in two different operons. The genes encoding the transmembrane domain (cbcW) and the nucleotide-binding domain (cbcV) are located in the cbcXWV operon (PA5378-PA5376) [18] , while the caiX gene, encoding the carnitine substrate-binding protein, is located in the carnitine catabolism operon caiXcdhCABhocS (PA5388-PA5384) [19] (Fig. 1b) . In P. aeruginosa, CbcWV interacts with three different substratebinding proteins, CaiX, BetX and CbcX, all of which bind QAC ligands: carnitine, glycine betaine and choline, respectively [18] . caiX and cbcWV were previously shown to be required for growth on carnitine [9, 19] , but the route for the acylcarnitine import in P. aeruginosa has not been studied.
Here we demonstrate that MCACs and LCACs are hydrolysed extracytoplasmically by unknown hydrolase(s) to yield carnitine and a fatty acid. Free carnitine, the carnitine liberated from MCACs and LCACs, and non-hydrolysed shortchain acylcarnitines are imported by the ABC transporter, CbcWV, and the substrate-binding protein, CaiX. These findings suggest a robust system for acylcarnitine transport in P. aeruginosa and provide a framework to explore acylcarnitine transport and utilization in other bacteria.
METHODS
Bacterial strains and compounds P. aeruginosa PA14 wild-type, DcaiX [19] and DcbcV [20] strains were maintained on Pseudomonas Isolation Agar (PIA) plates or in Lennox Broth (LB) liquid and supplemented with 50 or 40 µg ml À1 of gentamicin, respectively, when necessary. Carnitine and acylcarnitines were purchased from the following vendors: L-carnitine (Acros); 
Growth conditions
To test the growth of strains carrying deletions in transport components on carnitine and acylcarnitines (2-6 and 10-16 fatty acid chain length) as sole carbon sources, PA14 wildtype, DcaiX or DcbcV were grown overnight at 37 C in minimal media 3-(N-morpholino)propanesulfonic acid (MOPS) [21] with 20 mM pyruvate and 5 mM glucose with modifications as described previously [22] . Cells were collected by centrifugation, washed and inoculated at a final absorbance at 600 nm (OD 600 ) of 0.05 in MOPS with 20 mM of each individual acylcarnitine or carnitine. Cultures were grown at 37 C in a 48-well tissue culture plate on a horizontal shaker at 170 r.p.m. for 24 h. OD 600 was measured at the end of the assay on a Biotek Synergy2 plate reader. Due to the insolubility of palmitoylcarnitine in MOPS, growth on palmitoylcarnitine was determined by serial dilution and colony (c.f.u.) counts.
To test the use of carnitine and acylcarnitines as sole nitrogen sources, overnight cultures and preparation of the cells were the same as above. Cells were inoculated into nitrogenfree M63 minimal media [21] containing 20 mM pyruvate and 2 mM (for specific stereoisomers) and 4 mM (for racemic mixtures) of the acylcarnitine to be tested. Palmitoylcarnitine samples had deoxycholate added to 0.75 % to prevent precipitation. Cultures were grown at 37 C in a 48-well tissue culture plate on a horizontal shaker at 170 r.p.m. for 24 h. All acylcarnitine nitrogen source growth assays were measured on the Biotek Synergy2 plate reader at OD 600 .
Transcriptional reporter assay
To assess induction of caiX transcript in response to acylcarnitines in the transport-related deletion strains, DcaiX and DcbcV, we used the transcriptional reporter P caiX -lac-ZYA (pJAM22) [23] transformed into each strain by electroporation and selected on media with gentamicin. PA14 wild-type, DcaiX or DcbcV carrying pJAM22 were grown overnight at 37 C in MOPS medium with 20 mM pyruvate, 5 mM glucose and 20 µg ml À1 gentamicin. Cells were collected by centrifugation, washed and resuspended in MOPS minimal media. Cells were inoculated at a final OD 600 of 0.05 into a 48-well plate containing MOPS medium with 20 mM pyruvate, 20 µg ml À1 gentamicin and 1 mM of the induction compound (carnitine or acylcarnitines of 2-16 fatty acid chain length). Cells were incubated for 4 h at 37 C at 170 r.p.m. and then a b-galactosidase assay was performed according to Miller [24] . Due to insolubility of palmitoylcarnitine, OD 600 for those wells was measured prior to inoculation with cells and the pre-cell absorbance was subtracted from the final OD 600 reading.
Osmoprotection
Osmoprotection assays were done as previously described [9] , with a few modifications. Briefly, P. aeruginosa PA14 wild-type and DcbcV were grown overnight in MOPS medium with 20 mM pyruvate and 5 mM glucose. Cells were collected by centrifugation, washed and resuspended to an OD 600 of 0.05 in MOPS medium with an additional 800 mM NaCl (850 mM total NaCl), 20 mM glucose and 0.2 mM osmoprotectant (carnitine, acetylcarnitine, decanoylcarnitine or myristoylcarnitine). Then, 48-well plates were shaken at 37 C for 48 h at 170 r.p.m. and growth was determined by OD 600 .
Genetic screen
To generate a reporter parent strain for transposon mutagenesis, we started with a double deletion strain that produces no pyocyanin as it is lacking both phzA1-G1 and phzA2-G2 operons (generated by Diane Newman [25] , supplied by Dr Deborah Hogan as strain DH933 [26] ). This background eliminates the blue pyocyanin colour that can interfere with lacZ screening on minimal media plates. We cloned lacZYA from pMW5 [27] into the cdhAB deletion construct pMW99 [19] by amplifying with primers carrying appended restriction sites [BamH1 and KpnI via lacZ-F-BamH1 (5¢-ATTGTCGGATCCtgttctatagtaaCGTgaggaCTTtCCATGgT TACGGATTCACTGGCCGTCGTTTTA-3¢) and lacZ-RKpnI (5¢-agactGGTACCtgtggaattgtgagcggata-3¢)], to yield pMW226, which was transformed into S17lpir and conjugated with the phzA1-G1phzA2-G2 deletion strain. Single and double crossover mutants were selected as we have described [28] before to yield MJ696, carrying a lacZYA operonic fusion replacing cdhCAB, thus resulting in a carnitine auxotroph.
MJ696 was transposon mutagenized as we have done previously [28] , through conjugative mating with an Escherichia coli SM10 strain harbouring pBT20, which carries a mobilizable Mariner-based transposable element [29] . To accomplish this, we first confluently plated the MJ696 on LB agar and the E. coli SM10 donor strain on LB agar supplemented with 100 µg ml À1 of carbenicillin. The following day, the cells were scraped from each plate and gently resuspended in LB, and adjusted to cell densities of 40 OD 600 units (MJ696) and 20 OD 600 units (SM10-pBT20). These cultures were then mixed 1 : 1, and 50 µl aliquots were spot-plated on LB agar and incubated at 37 C for 1 h. Following the incubation, the mating spots were scraped, pooled, resuspended in MOPS media (1 ml per mating) and mixed with sterile glycerol to achieve a 10 % glycerol concentration. Then, 1 ml aliquots of this mating mixture were frozen at À80 C until screening. Transposon disruption mutants were simultaneously selected and screened for defects in the ability to transcriptionally respond to palmitoylcarnitine through plating on MOPS minimal media (no NH 4 Cl) agar supplemented with 2 % LB, 10 mM sodium pyruvate, 5 mM glucose, 120 µg ml À1 X-gal, 15 µg ml À1 gentamicin and 50 µM palmitoylcarnitine. P. aeruginosa gene disruption mutants that arose under these conditions were visually assessed for reduced or non-existent b-galactosidase activity against the background of abundant normal responders. Colonies meeting either criterion were then subjected to a secondary screen to determine if the observed defects were specific to LCACs (palmitoylcarnitine), or reflective of general defects related to the detection of carnitine alone. To accomplish this, these gene disruption mutants were first grown overnight in MOPS minimal media supplemented with 20 mM sodium pyruvate, 5 mM glucose and 15 µg ml À1 of gentamicin. The following day, the resulting cultures were serially diluted and spot-plated on the same MOPS minimal media agar described above, supplemented with either 50 µM palmitoylcarnitine or 25 µM carnitine as inducing compounds. The resulting b-galactosidase activity of each gene disruption mutant was then visually compared between conditions, as well as against three gene disruption mutants that exhibited a wild-type response in the primary screen that were included as controls.
The site of transposon insertion into the chromosome of P. aeruginosa mutants of interest were identified using a cloning-based strategy. Briefly, genomic DNA (gDNA) was isolated from transposon-tagged P. aeruginosa cultures via Qiagen's DNeasy kit and provided protocol. Isolated gDNA was digested with KpnI, purified using Thermo's GeneJet DNA clean up kit, and then ligated into similarly cut pUC19. The resulting ligations were transformed into chemically competent DH5a cells, which were then plated on LB agar supplemented with 10 µg ml À1 of gentamicin and 100 µg ml À1 of carbenicillin. Since pUC19 does not confer resistance to gentamicin, transformants can only survive this selection if the plasmid they harbour contains a fragment of the P. aeruginosa chromosome that encompasses the transposon insertion site containing this antibiotic resistance marker. Plasmid DNA was isolated from the colonies that arose via Qiagen's Miniprep Kit, which were then sequenced with a TnM-specific primer (BT20TnMSeq) [30] . The returned DNA sequences were then subjected to BLAST against the PA14 genome to identify the gene(s) disrupted by transposon insertion.
Microarray and follow-up phenotypic analyses
To differentiate the transcriptional responses of P. aeruginosa to LCACs and carnitine, we utilized a custom Affymetrix microarray chip to compare the transcriptional responses of PA14 cultured in MOPS minimal media containing 20 mM sodium pyruvate and either 4 mM palmitoylcarnitine or 2 mM carnitine as sole sources of nitrogen. For this experiment, P. aeruginosa PA14 was first cultured in modified MOPS minimal media supplemented with 25 mM sodium pyruvate and 5 mM glucose. Cells from the overnight culture were collected via centrifugation the following day, washed twice with 1 ml of modified MOPS media lacking ammonium chloride and resuspended in the same media supplemented with 20 mM sodium pyruvate to achieve an OD 600 of 0.6 units. This OD 600 -corrected culture was then mixed 1 : 1 in glass culture tubes containing MOPS media with 20 mM sodium pyruvate supplemented and either 8 mM palmitoylcarnitine or 4 mM carnitine as sole nitrogen sources, to achieve a final cell density of 0.3 OD 600 units, 20 mM sodium pyruvate and either 4 mM palmitoylcarnitine or 2 mM carnitine. These cultures were incubated at 37 C on a test tube roller wheel for 4 h. Following this induction period, each culture was centrifuged, and the resulting cell pellets were resuspended in 400 µl of MOPS media, immediately mixed with 800 µl of RNA Protect (Qiagen), and then frozen at À80 C as we have done previously [28] . Total RNA was isolated from these cultures using Qiagen's RNeasy kit, quantified through Qubit fluorometer, and assessed for purity via Agilent BioAnalyzer before being submitted to the UVM Advanced Genome Technology Core for library preparation and hybridization. The resulting probes were normalized for each gene using the Affymetrix Expression Console and Transcriptome Analysis Console (version 3.0), as we have done before [28] .
In addition to receiving the Dcif mutant from George O'Toole [31] , we created one to make sure our wild-type background would not contribute to altered expression. We generated to cif deletion as we have done previously [9, 28] . Briefly, we amplified approximately 1 kb of sequence up and downstream of cif, joined by splice-overlap extension PCR and cloned into pMQ30 [32] . Once this construct was verified by sequencing, it was transformed into E. coli S17lpir, which was the conjugation donor to transfer the cif deletion plasmid into the PA14 wild-type recipient. Single crossover integrants were selected on PIA with gentamicin, doublecrossovers selected for loss of sacB on LB with no salt and 5 % sucrose and mutants verified by PCR, resulting in the cif deletion strain MJ757. The pJAM22 plasmid (P caiX-lacZYA ) was transformed into MJ757, our PA14 wild-type (MJ79), and the original Dcif strain [31] , transformants selected on PIA gentamicin plates and transcriptional reporter assays using pyruvate, palmitoylcarnitine and carnitine were conducted as described above.
RESULTS
cbcV is required for growth and induction of caiX in response to SCACs In previous studies, we showed that P. aeruginosa can grow on the SCACs acetyl-and butyrylcarnitine [9] . SCACs are hydrolysed in the cytoplasm by HocS, and therefore must be imported prior to hydrolysis in order to be used as sole carbon and nitrogen sources. It has been shown that the genes encoding the substrate-binding protein CaiX [19] and the core components of the ABC transporter CbcWV are required for growth on carnitine [18] . We hypothesized that this ABC carnitine transport system has broader specificity and can import SCACs as well. The cbcV deletion strain was not able to grow on SCACs as the sole carbon sources (Fig. 2a) . Based on this growth data and the location of HocS in the cytosol [9] , we predicted that cbcWV was necessary for SCAC-dependent induction of caiX, the first gene in the carnitine catabolism operon (Fig. 1) . PA14 wild-type and the cbcV deletion mutant carrying the P caiX -lacZ plasmid (pJAM22) were induced with carnitine or SCACs, and expression from the caiX reporter was assessed by b-galactosidase assay. Carnitine and SCACs induced transcription of caiX in wild-type but in the cbcV deletion mutant, induction was greatly reduced (Fig. 2c) , likely due to the compounds not entering the cytoplasm. Taken together, the growth and reporter data indicate cbcWV is required for transport of SCACs.
CaiX is the substrate-binding protein for SCACs
CbcWV is the core ABC transporter for three QAC substrate-binding proteins -CaiX, BetX and CbcX [18] . Since cbcWV is required for transport of SCACs (Fig. 2) , this led us to investigate if CaiX was the substrate-binding proteins for SCACs, with the alternative possibility that there may be an additional independent substrate-binding protein that interacts with CbcWV for SCAC transport. To determine if caiX is required for SCAC transport we compared P. aeruginosa PA14 wild-type to the caiX mutant for their ability to grow on SCACs as sole nitrogen sources and b-galactosidase assays were performed as above on PA14 wild-type and the caiX mutant carrying the P caiX -lacZ plasmid (pJAM22). The caiX mutant was unable to grow on SCACs (Fig. 2b) , and could not induce the carnitine operon under these conditions (Fig. 2c) . These results support two conclusions: (i) caiX is required for growth on SCACs and (ii) we propose the ligand specificity of CaiX be expanded to include acetyl-and butyrylcarnitine.
Growth on MCACs and LCACs as carbon sources does not require cbcV Animal and plant cells use MCACs and LCACs as sources for and intermediates in b-oxidation [33, 34] , and we previously demonstrated that P. aeruginosa can use MCACs and LCACs as sole carbon sources [9] . We next tested if cbcWV was required for growth on MCACs and LCACs as sole carbon sources. PA14 wild-type and the isogenic cbcV deletion were able to grow in MOPS minimal media with acylcarnitines 6C and 10C-16C fatty acid chain lengths as sole carbon sources (Fig. 3) , though 6C growth was slower. These data suggest that MCACs and LCACs require an entirely different transport system or are hydrolysed outside of the cytosol from whence the free fatty acid can be imported to serve as a carbon source.
MCACs and LCACs are hydrolysed extracytoplasmically
To determine the route of MCAC and LCAC transport, we used the carnitine responsive transcriptional reporter pJAM22 (P caiX -lacZYA). Our rationale is that the presence of carnitine in the cytosol leads to caiX induction [9] . Thus, if acylcarnitines are transported into the cytoplasm and subsequently hydrolysed, the resulting free carnitine will induce caiX. Alternatively, hydrolysis outside the cytosol would require the liberated carnitine to be transported into the cytosol via CaiX and CbcWV to allow robust induction of caiX (Fig. 2) . Therefore, dependence on the free carnitine transporter components can allow us to determine whether medium-and long-chain hydrolysis happens inside or outside of the cytosol. Here we show that all acylcarnitine lengths allow induction, except for 8C (Fig. 4a) . Furthermore, the transcriptional induction from the caiX promoter is decreased over threefold in a caiX or a cbcV deletion mutant compared to the wild-type for 6C-16C acylcarnitines (Fig. 4b) , showing that caiX and cbcV are needed for robust induction of caiX. The residual induction in these mutants will be addressed in Discussion.
The lack of induction of caiX (Fig. 4b) while retaining the ability to grow in a cbcV mutant when MCAC and LCAC were sole carbon sources (Fig. 3) , led us to postulate that hydrolysis of these compounds occurs outside of the cytosol. A growth assay using 6C-16C acylcarnitines as sole nitrogen sources revealed that the caiX and cbcV deletion mutants failed to grow when compared to wild-type (Fig. 4c) . This carbon C before performing a Miller assay. Data shown are from three replicates and are representative of three independent experiments. Two-way ANOVA, NS, not significant; ***, P<0.001. Fig. 3 . MCACs and LCACs do not require cbcV for growth. Growth of wild-type and cbcV deletion mutant in MOPS with 20 mM of carnitine or acylcarnitines with 6-16 carbon fatty acid chain lengths. Growth was measured by OD 600 for all compounds except palmitoylcarnitine, which was determined by colony counts due to palmitoylcarnitine precipitation. The relative percentage growth was calculated as the mutant growth divided by wild-type growth multiplied by 100. Data shown are from three biological replicates and are representative of three independent experiments. Statistical significance calculated using a one-way ANOVA with Dunnett's multiple comparisons correction, with significance reported for each carbon source's wild-type growth as the comparitor. NS, not significant; *, P<0.05; ***, P<0.001. Fig. 4 . The role of caiX and cbcV on caiX promoter induction in the presence of acylcarnitines and growth when acylcarnitines are the sole nitrogen source. (a) b-galactosidase activities measured from wild-type P. aeruginosa carrying the P caiX -lacZ reporter plasmid (pJAM22) after induction in MOPS media with 20 mM pyruvate, 20 µg ml À1 gentamicin and 1 mM carnitine, or the acylcarnitines with 6-16 carbon tails as noted on the x-axis. Relative induction calculated as the enzymatic activity in each acylcarnitine divided by the induction in the presence of carnitine. (b) b-galactosidase activities measured from wild-type (wt), DcbcV (V) and DcaiX (X) carrying the P caiX -lacZ reporter plasmid (pJAM22) after induction in MOPS media with 20 mM pyruvate, 20 µg ml À1 gentamicin and 1 mM carnitine, or the acylcarnitines with 6-16 carbon tails as noted on the x-axis. Relative induction calculated as the enzymatic activities for each strain in each acylcarnitine divided by the enzymatic activity for wild-type cells exposed to that molecule. All mutant P caiX inductions are statistically different than wild-type on each acylcarnitine and therefore statistical significance is not specifically noted. (c) Growth of wild-type (WT), DcbcV (V) and DcaiX (X) cells in M63 minimal media after 24 h supplemented with 20 mM pyruvate and 2 mM of the nitrogen source labelled on the x-axis. Data shown are from three biological replicates and are representative of three independent experiments. Statistical significance for (a) calculated as for Fig. 3 , and calculated for (c) using a two-way ANOVA with Tukey's multiple comparisons correction, with significance reported for each carbon source's wild-type growth as the comparator. NS, not significant; *, P<0.05; ***, P<0.001.
source growth and caiX induction data indicate that hydrolysis of MCAC and LCAC occurs extracytoplasmically by an unidentified hydrolase(s) and CaiX binds the liberated carnitine for transport through CbcWV.
It has been demonstrated that cbcWV is important for growth on choline but is not necessary for osmoprotection in a hyperosmotic environment when choline is the osmoprotectant [20] . We predict this is similar for carnitine and that another transporter is sufficient for osmoprotection. PA14 wild-type and the isogenic cbcV mutant were grown in MOPS media at a final NaCl concentration of 850 mM, with 20 mM of glucose as the carbon source, and 0.2 mM of the potential osmoprotectants carnitine, acetylcarnitine, decanoylcarnitine or myristoylcarnitine. Carnitine, decanoylcarnitine and myristoylcarnitine can function as osmoprotectants in a cbcV mutant whereas acetylcarnitine cannot (Fig. 5) . Carnitine and the free carnitine generated from MCAC and LCAC hydrolysis outside the cytoplasm can thus circumvent CbcV by import through an unknown transporter to achieve osmoprotection. Acetylcarnitine, on the other hand, must first be imported into the cytoplasm by CaiX-CbcWV to allow for HocS hydrolysis in the cytosol in order to serve as an osmoprotectant [9] .
Genetic screening and transcriptome-guided search for an LCAC hydrolase
We constructed a carnitine-operon chromosomal reporter strain to assess induction from the carnitine-responsive caiX promoter. This strain was the target for Mariner transposon mutagenesis via conjugation with a pBT20-carrying E. coli l pir. After selection for transposon-positive P. aeruginosa on PIA with gentamicin, the full population was plated onto MOPS minimal media plates with palmitoylcarnitine (16C) and Xgal. We screened~80 000 colonies for the inability to induce b-galactosidase in the presence of palmitoylcarnitine (white or light blue). We initially found 127 hits, of which 33 were non-responsive (white) with the remainder exhibiting diminished responses to palmitoylcarnitine (light blue). A true LCAC hydrolase should have no defect when exposed to carnitine, but none of the primary screen hits passed this secondary screen for responsiveness to carnitine, either not showing their original defect, or having a phenotype responding to carnitine. Among the latter were transposon insertions into the high-flux carnitine transporter cbcWV [18, 20] , the carnitine-responsive transcriptional activator of carnitine operon cdhR [23] , and the lacZ reporter cassette. Multiple independent insertions into these genes [five into cbcX, cbcW or cbcV (the last presumed polar), three into cdhR and four into lacZ] suggests that our screen was effectively saturated. Using saturation rates and transposon library size, we calculate less than a 5 % chance that we simply missed a mutation in a non-essential single gene encoding this activity.
After not identifying a hydrolase(s) in the genetic screen, we performed a microarray comparing palmitoylcarnitine to carnitine, which showed that 84 transcripts were induced in palmitoylcarnitine compared to carnitine (Fig. 6a, Table S1 , available in the online version of this article). Many of these were involved in response to nitrogen stress, suggesting that even though P. aeruginosa can use palmitoylcarnitine as a nitrogen source, it was not used at the same rate as carnitine. This is supported by the growth rate of wild-type P. aeruginosa on palmitoylcarnitine, which is about half that on free carnitine when either one is the sole nitrogen source. Among the most highly induced transcripts, products of only two were known or potentially secreted (Cif and PA14_02060). We tested the transposon mutants in these two genes from the PA14nr library [35] and neither had a defect for utilization of palmitoylcarnitine. The most highly induced transcript was cif, encoding a well-studied epoxide hydrolase in P. aeruginosa [31, 36] . To ensure that we were not missing a phenotype in the transposon mutant strain, we generated our own cif deletion mutant and obtained the original cif deletion in PA14 from the O'Toole laboratory [31] and tested for their ability to induce the caiX reporter in response to palmitoylcarnitine. Both cif mutant strains showed no defect in this response compared to wild-type (Fig. 6b) , showing that while cif is strongly induced in these conditions (~11-fold), it does not contribute to palmitoylcarnitine utilization. Combined with the failure to identify a hydrolase via genetic screen, we suspect that hydrolysis of LCACs can be conducted by redundant hydrolases that may be constitutively expressed.
DISCUSSION
Acylcarnitines may be valuable carbon and nitrogen sources during infection, and their metabolic products carnitine and GB can function as osmoprotectants and induce the secreted phospholipase C virulence factor, PlcH [9, 10, 37] . The carnitine catabolic operon is induced in both burn and chronic wound models of P. aeruginosa infection, with twoto fourfold induction in burns and five-to 15-fold induction in deep wounds [38] . Although cbcXWV operon is not significantly induced in either of these conditions, the strong induction of the carnitine catabolic operon in deep wounds fits with the abundance of carnitine in this area, as carnitine is most abundant in muscle tissue in mammals. The carnitine catabolic operon was not induced in the presence of cystic fibrosis sputum [39] , which fits with the general low abundance of carnitine in the lung lumen.
In P. aeruginosa carnitine is transported by the substratebinding protein CaiX and the ABC transporter CbcWV [18, 19] , but no work to date has examined the acylcarnitine import. Our goal was to understand how acylcarnitines are imported and determine if there is any functional overlap between the carnitine and acylcarnitine transport systems. Using growth and reporter assays we show that MCACs and LCACs are hydrolysed extracytoplasmically and the free carnitine is transported into the cytosol by CaiX and CbcWV to be utilized as a sole nitrogen source. Carnitine and the free carnitine generated from MCAC and LCAC hydrolysis can function as an osmoprotectant, but cbcWV is not required. SCAC require caiX and cbcWV for transport into the cytoplasm and these genes are thus necessary for SCAC-dependent osmoprotection, expression of plcH, and use as carbon and nitrogen sources. These findings are summarized in the transport model shown in Fig. 7 .
OpuC is an ABC transporter in Bacillus subtilis that imports the structurally related QAC compounds carnitine, crotonobetaine and g-butyrobetaine [28] . The P. aeruginosa ABC transporter CbcWV is similar to B. subtilis OpuC and Fig. 6 . Transcriptional response to palmitoylcarnitine and determination that Cif does not play a role in LCAC hydrolysis. (a) Plot of microarray signal intensities for P. aeruginosa in the presence of carnitine or palmitoylcarnitine. Genes induced more than twofold are in blue, unchanged in grey and genes decreased more than twofold in red. Some of the most highly induced transcripts are labelled either with their gene name or PA14 gene number. (b) Deletion of cif does not alter transcription from the caiX promoter in response to palmitoylcarnitine. Wild-type (WT), our cif deletion (D) or the original cif deletion from the O'Toole lab (Do), were transformed with the pJAM22 reporter construct and assayed for b-galactosidase activity after exposure to the compounds listed below the x-axis. Activity is represented as fold induction above the pyruvate signal, with each strain normalized to its own pyruvate signal. Neither of the deletions was significantly different than wild-type as measured with a two-way ANOVA followed by a Sidak test. imports multiple QACs: glycine betaine, choline and carnitine [18] . The flexibility of these transport systems led us to determine if CbcWV is involved in the acylcarnitine import. Using growth assays with 2C-16C acylcarnitines (excluding octanoylcarnitine) as sole carbon sources, the cbcV mutant only showed a growth defect on SCACs, indicating that cbcV is not required for growth on MCACs and LCACs (Figs 2 and 4) . The substrate-binding protein is the other essential component of an ABC transporter. Not all substrate-binding proteins have a single ligand and some can promiscuously bind structurally similar compounds, as seen in B. subtilis [40, 41] , P. aeruginosa [18] , E. coli [42] and others [43] . In this study, we have extended the transport specificity of CaiX to encompass acetyl-and butyrylcarnitine, as a caiX deletion mutant fails to grow on SCACs as the sole carbon or nitrogen source. Physical interaction of SCACs with CaiX remains to be demonstrated. Taken together, these data suggested two possible methods of transport of MCACs and LCACs: extracytoplasmic hydrolysis yielding carnitine and a fatty acid, or alternatively, import through an unidentified transporter and cytoplasmic hydrolysis, in a manner similar to the SCACs [9] (Fig. 7 ).
Kappes and Bremer showed that B. subtilis can hydrolyse acetyl-and octanoylcarnitine but were not able to determine if hydrolysis was on the cell surface or inside the cell [41] . Using the P caiX -lacZ reporter and growth assays with these compounds as sole nitrogen sources, we showed that MCACs and LCACs are hydrolysed outside the cytoplasm and the liberated carnitine is transported primarily through CbcWV (Figs 4 and 5) . The ability of the cbcV and caiX mutants to use MCACs and LCACs as sole carbon sources but not as sole nitrogen sources indicates that the fatty acid functions as the predominant carbon source derived from these compounds (Fig. 5) . In the caiX and cbcV mutants there is residual P caiX -lacZ induction in the carnitine and acylcarnitine samples, which is due to transport of carnitine through an alternative transporter.
Carnitine, and to a lesser extent acylcarnitine, transport into the cell for osmoprotection is well-established [15] . Glycine betaine is the catabolic product of both carnitine and choline catabolism, thus linking these two pathways in P. aeruginosa. The initial import of choline occurs through BetT1 and BetT3, with BetT3 having additional roles in growth and osmoprotection [20] . Choline is catabolized to glycine betaine which then induces cbcWV in a GbdR-dependent manner, making cbcWV important for growth but not osmoprotection [20, 44] . Carnitine osmoprotection seems to function similarly, with cbcWV being required for growth but not osmoprotection (Fig. 5) . A carnitine transporter sufficient for osmoprotection has not been identified but may be a BCCT, as with choline, and could be one of the BetT family of transporters.
We previously reported that P. aeruginosa cannot utilize octanoylcarnitine as a sole carbon source [9] . Here we show octanoylcarnitine minimally induces caiX compared to carnitine in wild-type P. aeruginosa (Fig. 4) , indicating that hydrolysis is inefficient and is likely responsible for the inability of P. aeruginosa to grow on octanoylcarnitine [9] . Caprylic acid, the 8C chain fatty acid produced from octanoylcarnitine hydrolysis, has antibacterial properties and is commonly used in food preservation, medicine, cosmetics and agriculture [45] . Caprylic acid and other fatty acids inhibit growth or kill bacteria, such as Salmonella Enteritidis [46] , E. coli O157:H7 [47] , S. aureus [48] and P. aeruginosa [48, 49] , by disrupting the cell membrane and interfering with processes associated within or at the membrane, such as electron transport and oxidative phosphorylation [45] . The outer membrane acts as a semi-permeable barrier and defence mechanism [45, 50] , but octanoylcarnitine may circumvent this natural barrier if hydrolysis were to occur in the periplasm. P. aeruginosa may have evolved a hydrolase that excludes octanoylcarnitine as a substrate, in part to limit the detrimental effects of caprylic acid.
Our evidence demonstrates that MCACs and LCACs are hydrolysed extracytoplasmically. We took a two-pronged approach to identify the/a LCAC hydrolase (so-called 'HocL' as shown in Fig. 7 ) using both a genetic screen and a transcriptomics strategy. As described in Results, neither of these mechanisms yielded a gene necessary for LCAC hydrolysis. Considering the reasonable saturation of our screen, we propose that the most likely explanation is multiple redundant hydrolases capable of conducting this activity, and that their transcripts are likely not induced strongly in response to palmitoylcarnitine vs carnitine. However, this remains to be conclusively demonstrated. One or more of these redundant hydrolases need not be specific for LCACs. The possible role of a promiscuous hydrolase is the reason we chose to further examine the potential role of Cif in LCAC hydrolysis. While Cif is a well-studied epoxide hydrolase [31] and the substrate-binding and reaction mechanisms have been determined [51, 52] , it remained a formal possibility that Cif could contribute to LCAC hydrolysis. This possibility was eliminated by noting that neither our cif deletion nor the original cif deletion strain from the O'Toole lab were defective in response to palmitoylcarnitine. Thus, the LCAC hydrolase(s) remain unidentified. Given the failure of the forward genetic and transcriptomic approaches, identification of an LCAC hydrolase will likely require a biochemical strategy. The location for the LCAC hydrolase will also dictate the proteins required in the outer membrane: a periplasmic LCAC hydrolase would require an outer membrane pore or transporter capable of permitting intact LCAC access to the periplasm, whereas for hydrolysis on or outside the outer membrane, separate pores would be needed for carnitine and the liberated fatty acid. In our transcriptomic analysis, we detected no strongly induced transcript predicted to encode an orphan outer membrane pore or OM-linked transporter component. However, lack of transcriptional induction does not mean that such a system does not exist, and it would conceivably function like FadL in E. coli [53] and the mediators of long-chain AHL import in the Rhizobia [54] . Further studies pinpointing the location of the LCAC hydrolase(s) would inform us of the need for specific outer membrane components in this process.
This study expands our knowledge of P. aeruginosa metabolism and transport of acylcarnitines. MCACs and LCACs are hydrolysed extracytoplasmically by an unknown hydrolase to generate carnitine and a free fatty acid. Although cbcWV is not necessary for MCACs and LCACs to be used as carbon sources, CbcWV provides the only route for the extracytoplasmically liberated carnitine to be used as a nitrogen source. The liberated carnitine can also be used as an osmoprotectant via transport through an unidentified transporter, likely a BCCT family member. We also expanded the ligand specificity of CaiX to include acetyland butyrylcarnitine, promoting import via the ABC transporter CbcWV, which is required for SCACs to be used as osmoprotectants and as carbon and nitrogen sources.
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